Notably, there were four differentially overexpressed markers of type 1 inflammation unique to DM patients (IL12RB2, TNFRSF1A, and the ligand-receptor pair IL18-IL18R1), while they also exhibited markedly higher median expression of CXCL11 than the other groups. This evidence concerns the gene IL18R1 and dermatomyositis.